Final Destination: Bloodlines, the sixth entry in the long-running supernatural horror franchise, has officially crossed the coveted $100 million mark at the U.S. box office. By the end of its second full week in theaters, the film amassed $100.9 million domestically, becoming only the 10th horror film post-COVID to hit that milestone.
On its second Thursday, Bloodlines grossed $1.9 million, the highest second Thursday total in franchise history. This represented a modest 38.8% drop from the previous week and far outperformed 2009’s The Final Destination, which earned just $663K with a steeper decline. With strong word of mouth and steady weekday earnings, the film is projected to close its domestic run between $125–135 million.
Climbing the Horror Charts
Worldwide, Final Destination: Bloodlines has brought in $192.8 million, making it the highest-grossing and best-reviewed film in the franchise’s history. It’s set to surpass Alien: Romulus ($105.3M) to become the ninth-highest-grossing post-pandemic horror film in the U.S., and will soon enter the Top 30 highest-grossing horror films of all time domestically.
A Fresh Narrative with Familiar Chills
Directed by Zach Lipovsky and Adam Stein, from a story by Jon Watts and screenplay by Guy Busick and Lori Evans Taylor, Bloodlines stars Kaitlyn Santa Juana as a college student plagued by a deadly vision inherited from her grandmother. The cast also includes Teo Briones, Richard Harmon, Brec Bassinger, and series veteran Tony Todd.
Originally intended for HBO Max, the film received a theatrical release after delays from the SAG-AFTRA strike. It debuted in theaters on May 16, 2025, and has since revived the franchise with new energy, leaving fans hopeful for future installments.
